Glucuronic Acid Epimerase is Associated with Plasma Triglyceride and High-Density Lipoprotein Cholesterol Levels in Turks

Annals of Human Genetics

Volumn 75, Issue 3, 2011, Pages 398-417

  Hodoǧlugil, Uǧur ^a   Williamson, David W ^a   Yu, Yi ^d   Farrer, Lindsay A ^d,e   Mahley, Robert W ^a,b,c  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apolipoprotein E; GLCE; HDL C; Heparan sulfate proteoglycans; Single nucleotide polymorphisms; Triglyceride; Turks

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; EPIMERASE; GLUCURONIC ACID EPIMERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 15Q; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; HUMAN; LIPID DIET; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

ANIMALS; CARBOHYDRATE EPIMERASES; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROSATELLITE REPEATS; TRIGLYCERIDES; TURKEY;

MUS;

EID: 79954562216     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2011.00644.x     Document Type: Article

References (69)

1. Almasy, L. & Blangero, J. (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62, 1198-1211.
2. Almasy, L., Hixson, J. E., Rainwater, D. L., Cole, S., Williams, J. T., Mahaney, M. C., VandeBerg, J. L., Stern, M. P., MacCluer, J. W. & Blangero, J. (1999) Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet 64, 1686-1693.
3. Austin, M. A., Edwards, K. L., Monks, S. A., Koprowicz, K. M., Brunzell, J. D., Motulsky, A. G., Mahaney, M. C. & Hixson, J. E. (2003) Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia. J Lipid Res 44, 2161-2168.
4. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
5. Bersot, T. P., Vega, G. L., Grundy, S. M., Palaoǧlu, K. E., Atagündüz, P., Özbayrakçi, S., Gökdemir, O. & Mahley, R. W. (1999) Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res 40, 432-438.
6. Bishop, J. R., Schuksz, M. & Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037.
7. Bishop, J. R., Stanford, K. I. & Esko, J. D. (2008) Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism. Curr Opin Lipidol 19, 307-313.
8. Blake, J. A., Bult, C. J., Eppig, J. T., Kadin, J. A., Richardson, J. E. & Mouse Genome Database Group. (2009) The Mouse Genome Database genotypes::phenotypes. Nucleic Acids Res 37, D712-D719.
9. Burgess-Herbert, S. L., Tsaih, S.-W., Stylianou, I. M., Walsh, K., Cox, A. J. & Paigen, B. (2009) An experimental assessment of in silico haplotype association mapping in laboratory mice. BMC Genet 10, 81.
10. Casu, B. & Lindahl, U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 57, 159-206.
11. Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R. & Hobbs, H. H. (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305, 869-872.
12. Cohen, J. C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G. L., Grundy, S. M. & Hobbs, H. H. (2006) Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci USA 103, 1810-1815.
13. Dickson, S. P., Wang, K., Krantz, I., Hakonarson, H. & Goldstein, D. B. (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8, e1000294.
14. DiPetrillo, K., Wang, X., Stylianou, I. M. & Paigen, B. (2005) Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet 21, 683-692.
15. Falush, D., Stephens, M. & Pritchard, J. K. (2003) Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164, 1567-1587.
16. Feitosa, M. F., Province, M. A., Heiss, G., Arnett, D. K., Myers, R. H., Pankow, J. S., Hopkins, P. N. & Borecki, I. B. (2007) Evidence of QTL on 15q21 for high-density lipoprotein cholesterol: The National Heart, Lung, and Blood Institute Family Heart Study (NHLBI FHS). Atherosclerosis 190, 232-237.
17. Findley, C. V. (2005) Islam and empire from the Seljuks through the Mongols. In: The Turks in world history, pp. 56-92. New York Oxford University Press.
18. Frazer, K. A., Eskin, E., Kang, H. M., Bogue, M. A., Hinds, D. A., Beilharz, E. J., Gupta, R. V., Montgomery, J., Morenzoni, M. M., Nilsen, G. B., Pethiyagoda, C. L., Stuve, L. L., Johnson, F. M., Daly, M. J., Wade, C. M. & Cox, D. R. (2007) A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 448, 1050-1053.
19. Frye, R. N. (1996) The present is born. In: The heritage of central Asia: From antiquity to the Turkish expansion, pp. 233-239. Princeton, NJ Marcus Wiener Publishers.
20. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Jr., Bangdiwala, S. & Tyroler, H. A. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8-15.
21. Grousset, R. (1970) The Turks and Islam to the thirteenth century. In: The empire of the Steppes: A history of Central Asia, pp. 141-170. New Brunswick, NJ Rutgers University Press.
22. Guo, Y., Lu, P., Farrell, E., Zhang, X., Weller, P., Monshouwer, M., Wang, J., Liao, G., Zhang, Z., Hu, S., Allard, J., Shafer, S., Usuka, J. & Peltz, G. (2007) In silico and in vitro pharmacogenetic analysis in mice. Proc Natl Acad Sci USA 104, 17735-17740.
23. Güvenç, B. (1993) Türklerin Kimliǧi: Kim Bu Türkler? (Identity of Turks: Who are the Turks?). In: Türk Kimliǧi Kültür Tarihinin Kaynaklari (in Turkish) (Turkish Identity Sources of Cultural History), pp. 19-52. Ankara Kültür Bakanliǧi.
24. Heller, D. A., de Faire, U., Pedersen, N. L., Dahlén, G. & McClearn, G. E. (1993) Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328, 1150-1156.
25. Hiura, Y., Shen, C.-S., Kokubo, Y., Okamura, T., Morisaki, T., Tomoike, H., Yoshida, T., Sakamoto, H., Goto, Y., Nonogi, H. & Iwai, N. (2009) Identification of genetic markers associated with high-density lipoprotein-cholesterol by genome-wide screening in a Japanese population-the Suita Study. Circ J 73, 1119-1126.
26. Hodoǧlugil, U., Williamson, D. W., Huang, Y. & Mahley, R. W. (2005) Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis 183, 199-212.
27. Hodoǧlugil, U., Tanyolaç, S., Williamson, D. W., Huang, Y. & Mahley, R. W. (2006) Apolipoprotein A-V: A potential modulator of plasma triglyceride levels in Turks. J Lipid Res 47, 144-153.
28. Hodoǧlugil, U., Williamson, D. W. & Mahley, R. W. (2010) Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. J Lipid Res 51, 422-430.
29. Jacobs, D. R., Jr., Mebane, I. L., Bangdiwala, S. I., Criqui, M. H. & Tyroler, H. A. (1990) High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 131, 32-47.
30. Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., Wahlstrand, B., Hedner, T., Corella, D., Tai, E. S., Ordovas, J. M., Berglund, G., Vartiainen, E., Jousilahti, P., Hedblad, B., Taskinen, M.-R., Newton-Cheh, C., Salomaa, V., Peltonen, L., Groop, L., Altshuler, D. M. & Orho-Melander, M.(2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40, 189-197.
31. Ken-Dror, G., Goldbourt, U. & Dankner, R. (2010) Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins. J Hum Genet 55, 300-307.
32. Klimes, I., Weston, K., Kovacs, P., Gasperikova, D., Jezova, D., Kvetnansky, R., Thompson, J. R., Sebokova, E. & Samani, N. J. (2003) Mapping of genetic loci predisposing to hypertriglyceridaemia in the hereditary hypertriglyceridaemic rat: Analysis of genetic association with related traits of the insulin resistance syndrome. Diabetologia 46, 352-358.
33. Klos, K. L. E., Hamon, S., Clark, A. G., Boerwinkle, E., Liu, K. & Sing, C. F. (2005) APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study. J Lipid Res 46, 564-570.
34. Knoblauch, H., Bauerfeind, A., Toliat, M. R., Becker, C., Luganskaja, T., Günther, U. P., Rohde, K., Schuster, H., Junghans, C., Luft, F. C., Nürnberg, P. & Reich, J. G. (2004) Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet 13, 993-1004.
35. Li, J.-P., Gong, F., Hagner-McWhirter, Å., Forsberg, E., Åbrink, M., Kisilevsky, R., Zhang, X. & Lindahl, U. (2003) Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278, 28363-28366.
36. Li, J. Z., Absher, D. M., Tang, H., Southwick, A. M., Casto, A. M., Ramachandran, S., Cann, H. M., Barsh, G. S., Feldman, M., Cavalli-Sforza, L. L. & Myers, R. M. (2008) Worldwide human relationships inferred from genome-wide patterns of variation. Science 319, 1100-1104.
37. Li, X., Monda, K. L., Göring, H. H.H., Haack, K., Cole, S. A., Diego, V. P., Almasy, L., Laston, S., Howard, B. V., Shara, N. M., Lee, E. T., Best, L. G., Fabsitz, R. R., MacCluer, J. W. & North, K. E. (2009) Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: The Strong Heart Family Study. J Med Genet 46, 472-479.
38. MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L. & Esko, J. D. (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117, 153-164.
39. Mahaney, M. C., Blangero, J., Rainwater, D. L., Comuzzie, A. G., VandeBerg, J. L., Stern, M. P., MacCluer, J. W. & Hixson, J. E. (1995) A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study: Segregation and linkage analyses. Arterioscler Thromb Vasc Biol 15, 1730-1739.
40. Mahley, R. W., Palaoǧlu, K. E., Atak, Z., Dawson-Pepin, J., Langlois, A.-M., Cheung, V., Onat, H., Fulks, P., Mahley, L. L., Vakar, F., Özbayrakçi, S., Gökdemir, O. & Winkler, W. (1995) Turkish Heart Study: Lipids, lipoproteins, and apolipoproteins. J Lipid Res 36, 839-859.
41. Mahley, R. W., Huang, Y. & Rall, S. C., Jr. (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): Questions, quandaries, and paradoxes. J Lipid Res 40, 1933-1949.
42. Mahley, R. W. & Ji, Z.-S. (1999) Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40, 1-16.
43. Mahley, R. W., Can, S., Özbayrakçi, S., Bersot, T. P., Tanir, S., Palaoǧlu, K. E. & Pépin, G. M. (2005) Modulation of high-density lipoproteins in a population in Istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol 96, 547-555.
44. Mahley, R. W. & Huang, Y. (2007) Atherogenic remnant lipoproteins: Role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest 117, 94-98.
45. Mahley, R. W., Weisgraber, K. H. & Bersot, T. P. (2008) Disorders of lipid metabolism. In: Williams textbook of endocrinology (eds. H. M. Kronenberg, S. Melmed, K. S. Polonsky & P. R. Larsen), pp. 1589-1653. Philadelphia, PA Saunders.
46. Murray, C. J.L. & Lopez, A. D. (1997) Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet 349, 1269-1276.
47. Nakayama, K., Bayasgalan, T., Yamanaka, K., Kumada, M., Gotoh, T., Utsumi, N., Yanagisawa, Y., Okayama, M., Kajii, E., Ishibashi, S., Iwamoto, S. & the Jichi Community Genetics Team. (2009) Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J Med Genet 46, 370-374.
48. Ng, P. C. & Henikoff, S. (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res 12, 436-446.
49. Onat, A., Surdum-Avci, G., Senocak, M., Örnek, E. & Gözükara, Y. (1992) Plasma lipids and their interrelationship in Turkish adults. J Epidemiol Community Health 46, 470-476.
50. Porsch-Oezçueruemez, M., Bilgin, Y., Wollny, M., Gediz, A., Arat, A., Karatay, E., Akinci, A., Sinterhauf, K., Koch, H., Siegfried, I., von Georgi, R., Brenner, G. & Kloer, H.-U. (1999) Prevalence of risk factors of coronary heart disease in Turks living in Germany: The Giessen Study. Atherosclerosis 144, 185-198.
51. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J. & Sham, P. C. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
52. Rollins, J., Chen, Y., Paigen, B. & Wang, X. (2006) In search of new targets for plasma high-density lipoprotein cholesterol levels: Promise of human-mouse comparative genomics. Trends Cardiovasc Med 16, 220-234.
53. Rosenberg, N. A., Pritchard, J. K., Weber, J. L., Cann, H. M., Kidd, K. K., Zhivotovsky, L. A. & Feldman, M. W. (2002) Genetic structure of human populations. Science 298, 2381-2385.
54. Rosenberg, N. A. (2006) Standardized subsets of the HGDP-CEPH Human Genome Diversity Cell Line Panel, accounting for atypical and duplicated samples and pairs of close relatives. Ann Hum Genet 70, 841-847.
55. Spielman, R. S., McGinnis, R. E. & Ewens, W. J. (1993) Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52, 506-516.
56. Stanford, K. I., Wang, L., Castagnola, J., Song, D., Bishop, J. R., Brown, J. R., Lawrence, R., Bai, X., Habuchi, H., Tanaka, M., Cardoso, W. V., Kimata, K. & Esko, J. D. (2010) Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285, 286-294.
57. Sunyaev, S., Ramensky, V., Koch, I., Lathe III, W., Kondrashov, A. S. & Bork, P. (2001) Prediction of deleterious human alleles. Hum Mol Genet 10, 591-597.
58. y mice. Biochim Biophys Acta 1453, 385-395.
59. Svenson, K. L., Von Smith, R., Magnani, P. A., Suetin, H. R., Paigen, B., Naggert, J. K., Li, R., Churchill, G. A. & Peters, L. L. (2007) Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. J Appl Physiol 102, 2369-2378.
60. Tezcan, S., Altintaş, H., Sönmez, R., Akinci, A., Doǧan, B., Çakir, B., Bilgin, Y., Klör, H. U. & Razum, O. (2003) Cardiovascular risk factor levels in a lower middle-class community in Ankara, Turkey. Trop Med Int Health 8, 660-667.
61. The International HapMap Consortium. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861.
62. Utermann, G. (1985) Genetic polymorphism of apolipoprotein E - impact on plasma lipoprotein metabolism. In: Diabetes, obesity and hyperlipidemias - III (eds. G. Crepaldi, A. Tiengo & G. Baggio), pp. 1-28. Amsterdam Elsevier Science Publishers.
63. Wang, X., Korstanje, R., Higgins, D. & Paigen, B. (2004) Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 14, 1767-1772.
64. Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., Strait, J., Duren, W. L., Maschio, A., Busonero, F., Mulas, A., Albai, G., Swift, A. J., Morken, M. A., Narisu, N., Bennett, D., Parish, S., Shen, H., Galan, P., Meneton, P., Hercberg, S., Zelenika, D., Chen, W.-M., Li, Y., Scott, L. J., Scheet, P. A., Sundvall, J., Watanabe, R. M., Nagaraja, R., Ebrahim, S., Lawlor, D. A., Ben-Shlomo, Y., Davey-Smith, G., Shuldiner, A. R., Collins, R., Bergman, R. N., Uda, M., Tuomilehto, J., Cao, A., Collins, F. S., Lakatta, E., Lathrop, G. M., Boehnke, M., Schlessinger, D., Mohlke, K. L. & Abecasis, G. R. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40, 161-169.
65. Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W. & Swenson, T. L. (1992) Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem 267, 13284-13292.
66. Williams, K. J. & Fuki, I. V. (1997) Cell-surface heparan sulfate proteoglycans: Dynamic molecules mediating ligand catabolism. Curr Opin Lipidol 8, 253-262.
67. Wyszynski, D. F., Waterworth, D. M., Barter, P. J., Cohen, J., Kesäniemi, Y. A., Mahley, R. W., McPherson, R., Waeber, G., Bersot, T. P., Sharma, S. S., Nolan, V., Middleton, L. T., Sundseth, S. S., Farrer, L. A., Mooser, V. & Grundy, S. M. (2005) Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 95, 194-198.
68. Yang, R., Li, L., Seidelmann, S. B., Shen, G.-Q., Sharma, S., Rao, S., Abdullah, K. G., MacKinlay, K. G., Elston, R. C., Chen, Q., Topol, E. J. & Wang, Q. K. (2010) A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI. J Lipid Res 51, 1442-1451.
69. Yu, Y., Wyszynski, D. F., Waterworth, D. M., Wilton, S. D., Barter, P. J., Kesäniemi, Y. A., Mahley, R. W., McPherson, R., Waeber, G., Bersot, T. P., Ma, Q., Sharma, S. S., Montgomery, D. S., Middleton, L. T., Sundseth, S. S., Mooser, V., Grundy, S. M. & Farrer, L. A.(2005) Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res 46, 2202-2213.